GKB Ophthalmics Share Price
Small Cap | Pharmaceuticals and health care | BSE: 533212
₹75.27 
1.71 (2.32 %)
Last Updated: 13 Mar 2025 12:00 AM
BEARISH
Overview
Open (₹) 78.60
High (₹) 78.60
Low (₹) 73.03
Prev. Close (₹) 73.56
Volume 6,814
VWAP (₹) 80.77
ROCE (%) -1.19
Industry P/E 32.09
TTM P/E -8.60
P/B Ratio 0.59
Market Cap (₹) Cr.37.94
Dividend Yield (%)--
EPS (₹) -5.58
ROE-4.38%
Sales Growth (%) 16.93
Profit Growth (%)-3,618.05
Day Range
78.6078.60
52 Week Range
71.55136.40
Historical Returns
Returns (6M)
-34 %
Returns (1Y)
-5.3 %
Returns (3Y)
-16.87 %
Returns (5Y)
63.99 %
Returns (6M)
-34 %
Returns (1Y)
-5.3 %
Returns (3Y)
-16.87 %
Returns (5Y)
63.99 %
SWOT Analysis
- Company with (1590.91%) TTM EPS Growth
- Company with Low Debt
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
Technicals
Technical Rating
BEARISHRSI 51.24
MFI 19.93
ATR 6.03
Commodity Channel Index -87.77
ROC125 -32.24
ROC21 -8.97
Williams %R -70.98
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 84.16 | 87.01 | 91.04 | 80.13 | 77.28 | 73.25 | 70.40 |
| Week Ago | 84.48 | 86.98 | 88.97 | 82.49 | 79.99 | 78.00 | 75.50 |
| Month Ago | 91.05 | 92.35 | 94.75 | 88.65 | 87.35 | 84.95 | 83.65 |
EMA & SMA
75.27
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
20
5 Day 81.38
9 Day 80.82
10 Day 81.59
12 Day 83.81
14 Day 85.06
20 Day 87.71
26 Day 87.81
50 Day 92.29
100 Day 96.96
200 Day 102.02
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| BRIJENDRA KUMAR GUPTA | bulk | Sell | 10 Dec, 2024 | ₹103.68 | 37,625 | BSE |
| RAGINI CHETAN MEHTA | bulk | Sell | 29 Apr, 2024 | ₹132.75 | 818 | BSE |
| COUNTER CYCLICAL INVESTMENTS PRIVATE LIMITED | bulk | Sell | 29 Apr, 2024 | ₹136.40 | 79,754 | BSE |
| RAGINI CHETAN MEHTA | bulk | Buy | 29 Apr, 2024 | ₹135.89 | 27,869 | BSE |
| AMIT KUMAR JAIN HUF | bulk | Sell | 23 Apr, 2024 | ₹117.38 | 27,056 | BSE |
| AMIT KUMAR JAIN HUF | bulk | Buy | 23 Apr, 2024 | ₹120.26 | 17,056 | BSE |
| SANJIV KUMAR GUPTA | bulk | Sell | 10 Apr, 2023 | ₹113.99 | 28,121 | BSE |
| AGARWAL KUMAR RAJ | bulk | Sell | 24 Jan, 2023 | ₹173.70 | 29,874 | BSE |
| AGARWAL KUMAR RAJ | bulk | Sell | 28 Dec, 2022 | ₹103.85 | 29,000 | BSE |
| RAJASTHAN GLOBAL SECURITIES PRIVATE LIMITED | bulk | Buy | 28 Dec, 2022 | ₹103.63 | 33,419 | BSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 31 Dec, 2024 | Krishna Gopal Gupta & Sons HUF | Acquisition | ₹99.30 | 249 | BSE |
| 31 Dec, 2024 | Krishna Gopal Gupta & Sons HUF | Acquisition | ₹101.12 | 100 | BSE |
| 31 Dec, 2024 | Krishna Gopal Gupta & Sons HUF | Acquisition | ₹100.48 | 50 | BSE |
| 31 Dec, 2024 | Krishna Gopal Gupta | Acquisition | ₹100.23 | 500 | BSE |
| 31 Dec, 2024 | Krishna Gopal Gupta & Sons HUF | Acquisition | ₹101.14 | 621 | BSE |
| 31 Dec, 2024 | Krishna Gopal Gupta & Sons HUF | Acquisition | ₹99.67 | 330 | BSE |
| 20 Jun, 2024 | Gurudas Krishna Sawant | Acquisition | ₹94.91 | 425 | BSE |
| 30 Mar, 2024 | Krishna Gopal Gupta | Acquisition | ₹88.26 | 1,900 | BSE |
| 30 Mar, 2024 | Krishna Gopal Gupta & SonsHUF | Acquisition | ₹90.58 | 418 | BSE |
| 30 Mar, 2024 | Krishna Gopal Gupta & SonsHUF | Acquisition | ₹86.25 | 20 | BSE |
Corporate Actions
No corporate actions available.
Announcements
| Date | Source | Detail |
|---|---|---|
| 13 Feb, 2025 | BSE India | Pursuant to SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024, read with BSE circular no. 20250102-4 dated January 02, 2025, please find enclosed herewith Integrated filing (Financial) of the Company for the quarter and nine months ended December 31, 2024.\r\n\r\nThe above information will also be made available on the website of the Company at www.gkb.net.\r\n\r\nKindly take the above information on record. |
| 13 Feb, 2025 | BSE India | Please find enclosed the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024.\r\n\r\nThe unaudited financial results and the limited review reports are available on the company''s website www.gkb.net and the BSE website www.bseindia.com |
| 13 Feb, 2025 | BSE India | The meeting of the Board of Directors of the Company was held on February 13, 2025 which considered and took on record the unaudited standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024.\r\n\r\nThe above unaudited financial results and the limited review reports are available on the Company''s Website www.gkb.net and on BSE website www.bseindia.com.\r\n\r\nThe Board of Director''s meeting started at 4:15 P.M. and ended at 4:55 P.M. , on the same day.\r\n\r\nKindly take the information on record. |
| 06 Feb, 2025 | BSE India | Pursuant to Regulation 27(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015 read with SEBI Circular SEBI /HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated December 31, 2024 regarding Integrated Filing; please find attached the Integrated Corporate Governance Report for the quarter ended December 31, 2024 as per the format prescribed in the above mentioned SEBI Circular.\r\n\r\nPlease note that the said Corporate Governance Report has been filed in XBRL format as well, in addition to this Disclosure.\r\n\r\nKindly take the information on record. |
| 24 Jan, 2025 | BSE India | GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2024.\r\n\r\nThe Notice can be accessed at the Company''s Website at www.gkb.net\r\n\r\nFurther notices is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company, by designated person, under the SEBI (Prohibition of Insider Trading) Regulation, 2015, which has been closed , will now re- open on Monday , February 17, 2025.\r\n\r\n |
| 03 Jan, 2025 | BSE India | A meeting of the Board of Directors of the Company was held on January 03, 2025, which considered and approved the borrowing by way of an unsecured loan of upto Rs. 5.00 Crores ( Rupees Five Crores only) in tranches at rate of interest of 10.65% p.a. from GSV Ophthalmics Private Limited, a material subsidiary of the Company for the working capital requirements and general business purpose.\r\n\r\nFurther, the Board of Directors approved and executed the Loan Agreement on January 03, 2025 between the Company and GSV Ophthalmics Private Limited for an amount of upto Rs. 5.00 Crores to be availed by the Company in tranches.\r\n\r\nEnclosed please find the details of the Loan Agreement.\r\n\r\nThe meeting started at 11:35 A.M., and ended at 12.20 P.M. , on the same day.\r\n\r\nKindly take the information on record.\r\n\r\n |
| 02 Jan, 2025 | BSE India | This is to inform you that the material subsidiary of the Company, GSV Ophthalmics Private Limited in its Board Meeting held on December 30, 2024 and Extra Ordinary General Meeting with shorter notice held today, January 02, 2025 has approved to grant an unsecured loan of upto Rs. 5.00 Crores ( Rupees Five Crores Only) in tranches to GKB Ophthalmics Limited for the purpose of working capital requirements and general business purpose of the Company.\r\n\r\nThe Board meeting of GKB Ophthalmics Limited for consideration and approval of loan sanctioned by the Subsidiary Company, GSV Ophthalmics Private Limited will be held on Friday, January 03, 2025.\r\n\r\nKindly take the information on record. |
| 14 Nov, 2024 | BSE India | Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed please find a disclosure on Related Party Transaction on Consolidated basis for the half year ended September 30, 2024.\r\n\r\nKindly take the information on record.\r\n |
| 14 Nov, 2024 | BSE India | The Board of Directors in the meeting held on November 14, 2024 considered and took on record the Unaudited Standalone and Consolidate Financial Results for the quarter and half year ended September 30, 2024.\r\n\r\nKindly take information on record. |
| 14 Nov, 2024 | BSE India | The meeting of the Board of Directors of the company was held on November 14, 2024, which considered and took on record the Unaudited standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2024.\r\n\r\nThe above Unaudited Financial Results and the Limited Review Reports are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com.\r\n\r\nThe Board of Directors'' Meeting started at 04.15 P. M and ended at 05.05 P.M, on the same day.\r\n\r\nKindly take the information on record. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 25 Jan, 2025 | 13 Feb, 2025 |
| Quarterly Results | -- | 31 Oct, 2024 | 14 Nov, 2024 |
| Quarterly Results | -- | 22 Jul, 2024 | 13 Aug, 2024 |
| Audited Results | -- | 26 Apr, 2024 | 30 May, 2024 |
| Quarterly Results | -- | 31 Jan, 2024 | 14 Feb, 2024 |
| Quarterly Results | -- | 31 Oct, 2023 | 14 Nov, 2023 |
| Quarterly Results | -- | 28 Jul, 2023 | 11 Aug, 2023 |
| Audited Results | -- | 15 May, 2023 | 30 May, 2023 |
| Quarterly Results | -- | 01 Feb, 2023 | 14 Feb, 2023 |
| Quarterly Results | -- | 29 Jul, 2022 | 12 Aug, 2022 |
Share Holding Pattern
| Owner Name | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 | Sept, 2023 |
|---|
About GKB Ophthalmics
GKB Ophthalmics is a Public Limited Listed company incorporated on 10/12/1981 and has its registered office in the State of Goa, India. Company’s Corporate Identification Number(CIN) is L26109GA1981PLC000469 and registration number is 000469. Currently Company is involved in the business activities of Manufacture of ophthalmic goods, eyeglasses, sunglasses, lenses ground to prescription, contact lenses, safety goggles etc.. Company’s Total Operating Revenue is Rs. 31.18 Cr. and Equity Capital is Rs. 5.04 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1981
Managing Director
Mr. K G Gupta
NSE Symbol
--
GKB Ophthalmics Management
| Name | Designation |
|---|---|
| Mr. K G Gupta | Chairman & Managing Director |
| Mr. Vikram Gupta | Director |
| Mrs. Shashi Kumar Katreddi | Director |
| Mr. Purushottam S Mantri | Director |
| Mrs. Sandhya Ajit Kamat | Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Yash Optics & Lens | ₹180.42 | ₹72.85  ₹77.70(-6.24%) | ₹72.600 - ₹121.850 |
| Kretto Syscon | ₹117.28 | ₹1.87 ₹1.91(-2.09%) | ₹0.930 - ₹1.950 |
| GKB Ophthalmics | ₹37.94 | ₹75.27  ₹73.56(2.32%) | ₹71.550 - ₹136.400 |
FAQs on GKB Ophthalmics
What is the share price of GKB Ophthalmics?
The share price of GKB Ophthalmics on 13 Mar, 2025 is ₹ 75.27.
What is 52W high and 52W low share price of GKB Ophthalmics?
The highest and lowest 52W share prices of GKB Ophthalmics are ₹ 136.400 and ₹ 71.550
What is the market cap of GKB Ophthalmics?
The market capitalization of GKB Ophthalmics as of 13 Mar, 2025 is ₹ 37.94 Crores
What is the P/E ratio of GKB Ophthalmics?
The current P/E ratio of GKB Ophthalmics as of 13 Mar, 2025 is 32.09
What is the PB ratio of GKB Ophthalmics?
The PB ratio of GKB Ophthalmics as of 13 Mar, 2025 is 0.59
Top Gainers
₹41.02
₹34.29 (0.20%)
₹8.84
₹7.37 (0.20%)
₹6.97
₹5.81 (0.20%)
₹194.70
₹162.25 (0.20%)
Top Losers
₹13.75
₹135.15 (-0.90%)
₹9.60
₹12.00 (-0.20%)
₹9.80
₹93.55 (-0.90%)
₹0.99
₹4.77 (-0.79%)
Market Indices
Sensex
₹73,828.91
₹74,029.76 (0.00%)